Welltower Inc
Q1 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +6.60%.
Did WELL Beat Earnings? Q1 2026 Results
Welltower delivered a standout first quarter for 2026, with normalized FFO of $1.47 per diluted share beating the consensus estimate of $0.50 by 194.00% and revenue of $3.35 billion coming in 4.83% ahead of the $3.20 billion expected, representing 40.3% growth year-over-year. The primary engine behind the results was the Seniors Housing Operating segment, which posted 22.1% same-store NOI growth as occupancy climbed 370 basis points year-over-year to 89.0%, reflecting sustained demand across the company's senior housing portfolio. GAAP net income attributable to common stockholders reached $728.67 million, boosted in part by $420.40 million in net gains on real estate dispositions tied to significant capital recycling activity, including $3.30 billion of gross investments and $2.80 billion of dispositions during the quarter. Management raised its full-year 2026 normalized FFO guidance to $6.21 to $6.35 per diluted share, up from the prior range of $6.09 to $6.25, signaling continued confidence in senior housing fundamentals and the company's expanding investment pipeline.
- SHO same store NOI growth of 22.1% year-over-year driven by 370 bps average occupancy growth and 5.0% RevPOR growth
- Total portfolio SSNOI growth of 16.4%
- SHO same store occupancy reached 89.0%, up from 85.3% year-over-year
- SHO same store NOI margin improved to 30.9% from 27.7% year-over-year
- Net gains on real estate dispositions of $420.4 million
Forward Guidance & Outlook
Welltower raised full-year 2026 guidance: net income attributable to common stockholders revised to $3.24–$3.38 per diluted share (from $3.11–$3.27), and normalized FFO to $6.21–$6.35 per diluted share (from $6.09–$6.25). Same Store NOI growth expected at 12.25%–16.00% blended, comprising SHO approximately 16.5%–21.5%, SH Triple-net approximately 3.0%–4.0%, Outpatient Medical approximately 2.0%–3.0%, and Long-Term/Post-Acute Care approximately 2.0%–3.0%. G&A expenses anticipated at $263–$271 million with stock-based compensation of approximately $60 million. Pro rata disposition proceeds expected at $1.4 billion at a 6.7% blended yield over the next twelve months. Guidance includes only announced or closed acquisitions and no additional capital transactions.
WELL YoY Financials
WELL Revenue by Segment
WELL Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.